Stablix, Inc.

Stablix is pioneering an entirely new field of targeted protein stabilization (TPS) to bring transformative medicines to patients with unmet medical need.

biotechnology

United States

3960 Broadway

http://www.stablix.com

Last Updated : on 2021-06-01


Scott Kanner
Head of Platform Development and Co-Founder
Stablix, Inc.
Biotechnology

Kevin Sprott
SVP of Drug Discovery and Co-Founder
Stablix, Inc.
Biotechnology
United States
Boston
Carlo Rizzuto
Interim CEO
Stablix, Inc.
Biotechnology